nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—CYP3A4—Clindamycin—malaria	0.132	0.268	CbGbCtD
Danazol—CYP3A4—Sulfadiazine—malaria	0.0757	0.154	CbGbCtD
Danazol—CYP3A4—Artemether—malaria	0.0644	0.131	CbGbCtD
Danazol—CYP3A4—Proguanil—malaria	0.0606	0.123	CbGbCtD
Danazol—CYP3A4—Doxycycline—malaria	0.0574	0.116	CbGbCtD
Danazol—CYP3A4—Quinine—malaria	0.039	0.0792	CbGbCtD
Danazol—CYP3A4—Quinidine—malaria	0.0343	0.0696	CbGbCtD
Danazol—CYP3A4—Dapsone—malaria	0.0296	0.06	CbGbCtD
Danazol—CCL2—endothelium—malaria	0.013	0.107	CbGeAlD
Danazol—CCL2—blood plasma—malaria	0.0115	0.095	CbGeAlD
Danazol—Vulvovaginal dryness—Clindamycin—malaria	0.0103	0.0405	CcSEcCtD
Danazol—CCL2—GMCSF-mediated signaling events—CISH—malaria	0.00767	0.0583	CbGpPWpGaD
Danazol—SHBG—blood plasma—malaria	0.00672	0.0554	CbGeAlD
Danazol—CCL2—hematopoietic system—malaria	0.00637	0.0525	CbGeAlD
Danazol—CCL2—kidney—malaria	0.00522	0.043	CbGeAlD
Danazol—CCL2—Vitamin B12 Metabolism—HBB—malaria	0.00521	0.0396	CbGpPWpGaD
Danazol—Epigastric pain—Quinidine—malaria	0.00474	0.0186	CcSEcCtD
Danazol—Epigastric pain—Quinine—malaria	0.00474	0.0186	CcSEcCtD
Danazol—CCL2—digestive system—malaria	0.00443	0.0365	CbGeAlD
Danazol—Epigastric pain—Quinidine barbiturate—malaria	0.00428	0.0168	CcSEcCtD
Danazol—CCL2—Folate Metabolism—HBB—malaria	0.00424	0.0322	CbGpPWpGaD
Danazol—CCL2—blood—malaria	0.00422	0.0348	CbGeAlD
Danazol—CCL2—bone marrow—malaria	0.00408	0.0337	CbGeAlD
Danazol—Pelvic pain—Clindamycin—malaria	0.00384	0.0151	CcSEcCtD
Danazol—SHBG—hematopoietic system—malaria	0.00372	0.0306	CbGeAlD
Danazol—CCL2—IL1 and megakaryotyces in obesity—IL18—malaria	0.00358	0.0272	CbGpPWpGaD
Danazol—CCL2—IL23-mediated signaling events—IL12B—malaria	0.00345	0.0262	CbGpPWpGaD
Danazol—Seborrhoeic dermatitis—Clindamycin—malaria	0.00343	0.0135	CcSEcCtD
Danazol—CCL2—Selenium Micronutrient Network—HBB—malaria	0.00337	0.0256	CbGpPWpGaD
Danazol—Stevens-Johnson syndrome—Pyrimethamine—malaria	0.00336	0.0132	CcSEcCtD
Danazol—GNRHR—brain—malaria	0.00335	0.0277	CbGeAlD
Danazol—PGR—hematopoietic system—malaria	0.00335	0.0276	CbGeAlD
Danazol—GNRHR—Peptide GPCRs—ACKR1—malaria	0.00332	0.0253	CbGpPWpGaD
Danazol—PGR—Validated nuclear estrogen receptor alpha network—MPG—malaria	0.0033	0.0251	CbGpPWpGaD
Danazol—CCL2—liver—malaria	0.0033	0.0272	CbGeAlD
Danazol—Haematuria—Pyrimethamine—malaria	0.00324	0.0127	CcSEcCtD
Danazol—CYP19A1—hematopoietic system—malaria	0.00301	0.0248	CbGeAlD
Danazol—CCL2—Vitamin B12 Metabolism—SCARB1—malaria	0.0029	0.022	CbGpPWpGaD
Danazol—Erythema multiforme—Pyrimethamine—malaria	0.00288	0.0113	CcSEcCtD
Danazol—Throat sore—Pentoxifylline—malaria	0.00286	0.0113	CcSEcCtD
Danazol—Oropharyngeal discomfort—Pentoxifylline—malaria	0.00284	0.0112	CcSEcCtD
Danazol—GNRHR—GPCRs, Other—ACKR1—malaria	0.00282	0.0214	CbGpPWpGaD
Danazol—Acne—Clindamycin—malaria	0.00278	0.0109	CcSEcCtD
Danazol—CCL2—IL1 and megakaryotyces in obesity—ICAM1—malaria	0.00275	0.0209	CbGpPWpGaD
Danazol—AR—hematopoietic system—malaria	0.00267	0.022	CbGeAlD
Danazol—CYP3A4—blood plasma—malaria	0.00264	0.0218	CbGeAlD
Danazol—CCL2—brain—malaria	0.00262	0.0216	CbGeAlD
Danazol—ESR1—hematopoietic system—malaria	0.00262	0.0216	CbGeAlD
Danazol—CCL2—IL23-mediated signaling events—IL18—malaria	0.00253	0.0192	CbGpPWpGaD
Danazol—Leukocytosis—Clindamycin—malaria	0.00249	0.00977	CcSEcCtD
Danazol—SHBG—blood—malaria	0.00246	0.0203	CbGeAlD
Danazol—SHBG—bone marrow—malaria	0.00238	0.0196	CbGeAlD
Danazol—CCL2—Folate Metabolism—DHFR—malaria	0.00238	0.0181	CbGpPWpGaD
Danazol—Leukopenia—Pyrimethamine—malaria	0.00237	0.00933	CcSEcCtD
Danazol—CCL2—Folate Metabolism—SCARB1—malaria	0.00236	0.0179	CbGpPWpGaD
Danazol—Oropharyngeal pain—Pentoxifylline—malaria	0.00227	0.00893	CcSEcCtD
Danazol—PGR—blood—malaria	0.00222	0.0183	CbGeAlD
Danazol—PGR—Cellular roles of Anthrax toxin—IL18—malaria	0.00221	0.0168	CbGpPWpGaD
Danazol—AR—kidney—malaria	0.00219	0.018	CbGeAlD
Danazol—ESR1—kidney—malaria	0.00215	0.0177	CbGeAlD
Danazol—Thrombocytopenia—Pyrimethamine—malaria	0.00212	0.00833	CcSEcCtD
Danazol—CCL2—IL1 and megakaryotyces in obesity—IFNG—malaria	0.00209	0.0159	CbGpPWpGaD
Danazol—CYP19A1—blood—malaria	0.002	0.0165	CbGeAlD
Danazol—ESR1—Validated nuclear estrogen receptor alpha network—MPG—malaria	0.00194	0.0147	CbGpPWpGaD
Danazol—CCL2—IL23-mediated signaling events—NOS2—malaria	0.00193	0.0147	CbGpPWpGaD
Danazol—Pancreatitis—Sulfadiazine—malaria	0.00193	0.00759	CcSEcCtD
Danazol—SHBG—liver—malaria	0.00192	0.0159	CbGeAlD
Danazol—Photosensitivity—Quinine—malaria	0.00189	0.00745	CcSEcCtD
Danazol—Photosensitivity—Quinidine—malaria	0.00189	0.00745	CcSEcCtD
Danazol—CCL2—Selenium Micronutrient Network—SCARB1—malaria	0.00187	0.0142	CbGpPWpGaD
Danazol—CCL2—IL1 and megakaryotyces in obesity—IL1B—malaria	0.00187	0.0142	CbGpPWpGaD
Danazol—AR—digestive system—malaria	0.00185	0.0153	CbGeAlD
Danazol—ESR1—digestive system—malaria	0.00182	0.015	CbGeAlD
Danazol—AR—blood—malaria	0.00177	0.0146	CbGeAlD
Danazol—Visual disturbance—Quinidine—malaria	0.00176	0.0069	CcSEcCtD
Danazol—Visual disturbance—Quinine—malaria	0.00176	0.0069	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Sulfadiazine—malaria	0.00174	0.00684	CcSEcCtD
Danazol—ESR1—blood—malaria	0.00173	0.0143	CbGeAlD
Danazol—Sleep disorder—Pentoxifylline—malaria	0.00173	0.00681	CcSEcCtD
Danazol—Photosensitivity—Quinidine barbiturate—malaria	0.00171	0.00672	CcSEcCtD
Danazol—CCL2—Peptide ligand-binding receptors—ACKR1—malaria	0.00171	0.013	CbGpPWpGaD
Danazol—Nasal congestion—Pentoxifylline—malaria	0.00165	0.00647	CcSEcCtD
Danazol—CCL2—Vitamin B12 Metabolism—CRP—malaria	0.00164	0.0125	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—FCGR2A—malaria	0.00161	0.0123	CbGpPWpGaD
Danazol—Visual disturbance—Quinidine barbiturate—malaria	0.00158	0.00623	CcSEcCtD
Danazol—CYP19A1—liver—malaria	0.00156	0.0129	CbGeAlD
Danazol—Abdominal pain upper—Clindamycin—malaria	0.00155	0.00609	CcSEcCtD
Danazol—CCL2—Folate Metabolism—IL4—malaria	0.00154	0.0117	CbGpPWpGaD
Danazol—SHBG—brain—malaria	0.00153	0.0126	CbGeAlD
Danazol—Cramp muscle—Clindamycin—malaria	0.00153	0.006	CcSEcCtD
Danazol—Abdominal pain upper—Quinine—malaria	0.00152	0.00597	CcSEcCtD
Danazol—Abdominal pain upper—Quinidine—malaria	0.00152	0.00597	CcSEcCtD
Danazol—CCL2—AP-1 transcription factor network—IL10—malaria	0.00151	0.0115	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—ICAM1—malaria	0.00151	0.0115	CbGpPWpGaD
Danazol—Erythema multiforme—Sulfadiazine—malaria	0.00149	0.00586	CcSEcCtD
Danazol—Pancreatitis—Dapsone—malaria	0.00149	0.00584	CcSEcCtD
Danazol—CCL2—IL23-mediated signaling events—IFNG—malaria	0.00148	0.0113	CbGpPWpGaD
Danazol—Affect lability—Quinidine barbiturate—malaria	0.00148	0.00581	CcSEcCtD
Danazol—ESR1—Leptin signaling pathway—CISH—malaria	0.00147	0.0112	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—IL4—malaria	0.00147	0.0112	CbGpPWpGaD
Danazol—CYP3A4—hematopoietic system—malaria	0.00146	0.012	CbGeAlD
Danazol—Eosinophilia—Clindamycin—malaria	0.00145	0.00571	CcSEcCtD
Danazol—Irritability—Quinidine barbiturate—malaria	0.00143	0.00563	CcSEcCtD
Danazol—CCL2—IL23-mediated signaling events—CD4—malaria	0.00143	0.0109	CbGpPWpGaD
Danazol—Mood swings—Quinidine barbiturate—malaria	0.00142	0.00559	CcSEcCtD
Danazol—Chills—Sulfadiazine—malaria	0.00141	0.00556	CcSEcCtD
Danazol—Photosensitivity reaction—Dapsone—malaria	0.00138	0.00544	CcSEcCtD
Danazol—AR—liver—malaria	0.00138	0.0114	CbGeAlD
Danazol—Vomiting—Pyrimethamine—malaria	0.00138	0.00541	CcSEcCtD
Danazol—PGR—brain—malaria	0.00138	0.0113	CbGeAlD
Danazol—Abdominal pain upper—Quinidine barbiturate—malaria	0.00137	0.00539	CcSEcCtD
Danazol—ESR1—liver—malaria	0.00136	0.0112	CbGeAlD
Danazol—Photosensitivity reaction—Clindamycin—malaria	0.00134	0.00526	CcSEcCtD
Danazol—CCL2—Folate Metabolism—CRP—malaria	0.00133	0.0101	CbGpPWpGaD
Danazol—Body temperature increased—Proguanil—malaria	0.00133	0.00524	CcSEcCtD
Danazol—CCL2—IL23-mediated signaling events—IL1B—malaria	0.00132	0.0101	CbGpPWpGaD
Danazol—CCL2—IL23-mediated signaling events—IL2—malaria	0.00132	0.01	CbGpPWpGaD
Danazol—Photosensitivity reaction—Quinine—malaria	0.00131	0.00516	CcSEcCtD
Danazol—Photosensitivity reaction—Quinidine—malaria	0.00131	0.00516	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Clindamycin—malaria	0.0013	0.00509	CcSEcCtD
Danazol—Jaundice—Clindamycin—malaria	0.00127	0.00501	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Quinine—malaria	0.00127	0.005	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Quinidine—malaria	0.00127	0.005	CcSEcCtD
Danazol—Jaundice—Quinine—malaria	0.00125	0.00491	CcSEcCtD
Danazol—Jaundice—Quinidine—malaria	0.00125	0.00491	CcSEcCtD
Danazol—CYP19A1—brain—malaria	0.00124	0.0102	CbGeAlD
Danazol—Vertigo—Sulfadiazine—malaria	0.00123	0.00484	CcSEcCtD
Danazol—Sweating—Quinidine—malaria	0.00123	0.00483	CcSEcCtD
Danazol—Sweating—Quinine—malaria	0.00123	0.00483	CcSEcCtD
Danazol—Leukopenia—Sulfadiazine—malaria	0.00123	0.00483	CcSEcCtD
Danazol—CCL2—Folate Metabolism—ICAM1—malaria	0.00123	0.00932	CbGpPWpGaD
Danazol—CYP3A4—kidney—malaria	0.0012	0.00987	CbGeAlD
Danazol—Convulsion—Sulfadiazine—malaria	0.00119	0.00467	CcSEcCtD
Danazol—Photosensitivity reaction—Quinidine barbiturate—malaria	0.00118	0.00466	CcSEcCtD
Danazol—Arthralgia—Sulfadiazine—malaria	0.00117	0.00459	CcSEcCtD
Danazol—ESR1—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.00116	0.00882	CbGpPWpGaD
Danazol—Haemoglobin—Quinidine—malaria	0.00116	0.00455	CcSEcCtD
Danazol—Haemoglobin—Quinine—malaria	0.00116	0.00455	CcSEcCtD
Danazol—PGR—Cellular roles of Anthrax toxin—IL1B—malaria	0.00116	0.00879	CbGpPWpGaD
Danazol—Haemorrhage—Quinine—malaria	0.00115	0.00453	CcSEcCtD
Danazol—Haemorrhage—Quinidine—malaria	0.00115	0.00453	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Quinidine barbiturate—malaria	0.00115	0.00451	CcSEcCtD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	0.00115	0.00872	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—IFNG—malaria	0.00115	0.00872	CbGpPWpGaD
Danazol—Jaundice—Quinidine barbiturate—malaria	0.00113	0.00443	CcSEcCtD
Danazol—Jaundice—Pentoxifylline—malaria	0.00113	0.00443	CcSEcCtD
Danazol—Erythema multiforme—Clindamycin—malaria	0.00111	0.00436	CcSEcCtD
Danazol—Sweating—Quinidine barbiturate—malaria	0.00111	0.00436	CcSEcCtD
Danazol—Visual impairment—Quinidine—malaria	0.00111	0.00436	CcSEcCtD
Danazol—Visual impairment—Quinine—malaria	0.00111	0.00436	CcSEcCtD
Danazol—Sweating—Pentoxifylline—malaria	0.00111	0.00435	CcSEcCtD
Danazol—AR—brain—malaria	0.0011	0.00904	CbGeAlD
Danazol—Thrombocytopenia—Sulfadiazine—malaria	0.0011	0.00431	CcSEcCtD
Danazol—Flushing—Clindamycin—malaria	0.00109	0.00428	CcSEcCtD
Danazol—Erythema multiforme—Quinidine—malaria	0.00109	0.00428	CcSEcCtD
Danazol—Erythema multiforme—Quinine—malaria	0.00109	0.00428	CcSEcCtD
Danazol—ESR1—brain—malaria	0.00108	0.00887	CbGeAlD
Danazol—Vomiting—Proguanil—malaria	0.00107	0.00422	CcSEcCtD
Danazol—Flushing—Quinine—malaria	0.00107	0.0042	CcSEcCtD
Danazol—Flushing—Quinidine—malaria	0.00107	0.0042	CcSEcCtD
Danazol—Rash—Proguanil—malaria	0.00106	0.00418	CcSEcCtD
Danazol—Dermatitis—Proguanil—malaria	0.00106	0.00418	CcSEcCtD
Danazol—CCL2—Selenium Micronutrient Network—CRP—malaria	0.00106	0.00805	CbGpPWpGaD
Danazol—Headache—Proguanil—malaria	0.00106	0.00415	CcSEcCtD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	0.00105	0.00798	CbGpPWpGaD
Danazol—Haemoglobin—Quinidine barbiturate—malaria	0.00104	0.0041	CcSEcCtD
Danazol—Haemoglobin—Pentoxifylline—malaria	0.00104	0.0041	CcSEcCtD
Danazol—Haemorrhage—Quinidine barbiturate—malaria	0.00104	0.00408	CcSEcCtD
Danazol—Haemorrhage—Pentoxifylline—malaria	0.00104	0.00408	CcSEcCtD
Danazol—Chills—Quinidine—malaria	0.00103	0.00406	CcSEcCtD
Danazol—Chills—Quinine—malaria	0.00103	0.00406	CcSEcCtD
Danazol—CCL2—Vitamin B12 Metabolism—IL1B—malaria	0.00102	0.00777	CbGpPWpGaD
Danazol—Musculoskeletal discomfort—Sulfadiazine—malaria	0.00102	0.00401	CcSEcCtD
Danazol—CYP3A4—digestive system—malaria	0.00102	0.00838	CbGeAlD
Danazol—CCL2—Metabolism of proteins—NANP—malaria	0.00101	0.00771	CbGpPWpGaD
Danazol—Nausea—Proguanil—malaria	0.001	0.00394	CcSEcCtD
Danazol—Visual impairment—Quinidine barbiturate—malaria	0.001	0.00394	CcSEcCtD
Danazol—Vision blurred—Dapsone—malaria	0.000995	0.00391	CcSEcCtD
Danazol—Back pain—Clindamycin—malaria	0.000988	0.00388	CcSEcCtD
Danazol—Erythema multiforme—Quinidine barbiturate—malaria	0.000982	0.00386	CcSEcCtD
Danazol—Muscle spasms—Clindamycin—malaria	0.000982	0.00386	CcSEcCtD
Danazol—CCL2—Selenium Micronutrient Network—ICAM1—malaria	0.000974	0.0074	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—IL4—malaria	0.000969	0.00737	CbGpPWpGaD
Danazol—CYP3A4—blood—malaria	0.000968	0.00798	CbGeAlD
Danazol—Flushing—Quinidine barbiturate—malaria	0.000964	0.00379	CcSEcCtD
Danazol—CCL2—IL-1 signaling pathway—IL1B—malaria	0.000962	0.00732	CbGpPWpGaD
Danazol—Flushing—Pentoxifylline—malaria	0.000962	0.00378	CcSEcCtD
Danazol—CCL2—IL23-mediated signaling events—TNF—malaria	0.000959	0.00729	CbGpPWpGaD
Danazol—Vertigo—Dapsone—malaria	0.000948	0.00373	CcSEcCtD
Danazol—Vision blurred—Quinidine—malaria	0.000944	0.00371	CcSEcCtD
Danazol—Vision blurred—Quinine—malaria	0.000944	0.00371	CcSEcCtD
Danazol—Tremor—Quinidine—malaria	0.000939	0.00369	CcSEcCtD
Danazol—Tremor—Quinine—malaria	0.000939	0.00369	CcSEcCtD
Danazol—CCL2—Folate Metabolism—IFNG—malaria	0.000932	0.00709	CbGpPWpGaD
Danazol—Chills—Quinidine barbiturate—malaria	0.000932	0.00366	CcSEcCtD
Danazol—Vertigo—Clindamycin—malaria	0.000917	0.00361	CcSEcCtD
Danazol—Leukopenia—Clindamycin—malaria	0.000914	0.00359	CcSEcCtD
Danazol—Vertigo—Quinine—malaria	0.0009	0.00354	CcSEcCtD
Danazol—Vertigo—Quinidine—malaria	0.0009	0.00354	CcSEcCtD
Danazol—Syncope—Quinidine—malaria	0.000898	0.00353	CcSEcCtD
Danazol—Syncope—Quinine—malaria	0.000898	0.00353	CcSEcCtD
Danazol—Leukopenia—Quinidine—malaria	0.000897	0.00353	CcSEcCtD
Danazol—Leukopenia—Quinine—malaria	0.000897	0.00353	CcSEcCtD
Danazol—CCL2—AP-1 transcription factor network—IFNG—malaria	0.00089	0.00677	CbGpPWpGaD
Danazol—Urticaria—Sulfadiazine—malaria	0.000889	0.0035	CcSEcCtD
Danazol—Tension—Quinidine barbiturate—malaria	0.000887	0.00349	CcSEcCtD
Danazol—Tension—Pentoxifylline—malaria	0.000886	0.00348	CcSEcCtD
Danazol—Palpitations—Quinine—malaria	0.000885	0.00348	CcSEcCtD
Danazol—Palpitations—Quinidine—malaria	0.000885	0.00348	CcSEcCtD
Danazol—Body temperature increased—Sulfadiazine—malaria	0.000885	0.00348	CcSEcCtD
Danazol—Hypertension—Clindamycin—malaria	0.000882	0.00347	CcSEcCtD
Danazol—Loss of consciousness—Quinidine—malaria	0.00088	0.00346	CcSEcCtD
Danazol—Loss of consciousness—Quinine—malaria	0.00088	0.00346	CcSEcCtD
Danazol—Nervousness—Quinidine barbiturate—malaria	0.000878	0.00345	CcSEcCtD
Danazol—Nervousness—Pentoxifylline—malaria	0.000877	0.00345	CcSEcCtD
Danazol—CCL2—GPCR ligand binding—ACKR1—malaria	0.000873	0.00664	CbGpPWpGaD
Danazol—Back pain—Pentoxifylline—malaria	0.000873	0.00343	CcSEcCtD
Danazol—Convulsion—Quinine—malaria	0.000868	0.00341	CcSEcCtD
Danazol—Convulsion—Quinidine—malaria	0.000868	0.00341	CcSEcCtD
Danazol—Muscle spasms—Pentoxifylline—malaria	0.000868	0.00341	CcSEcCtD
Danazol—CCL2—TWEAK Signaling Pathway—TNF—malaria	0.000866	0.00659	CbGpPWpGaD
Danazol—Vision blurred—Quinidine barbiturate—malaria	0.000852	0.00335	CcSEcCtD
Danazol—Vision blurred—Pentoxifylline—malaria	0.000851	0.00334	CcSEcCtD
Danazol—Tremor—Quinidine barbiturate—malaria	0.000847	0.00333	CcSEcCtD
Danazol—Tremor—Pentoxifylline—malaria	0.000846	0.00332	CcSEcCtD
Danazol—Tachycardia—Dapsone—malaria	0.000841	0.00331	CcSEcCtD
Danazol—PGR—Cellular roles of Anthrax toxin—TNF—malaria	0.000838	0.00638	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—IL1B—malaria	0.000832	0.00633	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—IL2—malaria	0.000829	0.0063	CbGpPWpGaD
Danazol—Oedema—Quinine—malaria	0.000818	0.00321	CcSEcCtD
Danazol—Oedema—Quinidine—malaria	0.000818	0.00321	CcSEcCtD
Danazol—Thrombocytopenia—Clindamycin—malaria	0.000816	0.00321	CcSEcCtD
Danazol—Vertigo—Quinidine barbiturate—malaria	0.000812	0.00319	CcSEcCtD
Danazol—Syncope—Quinidine barbiturate—malaria	0.000811	0.00319	CcSEcCtD
Danazol—Leukopenia—Quinidine barbiturate—malaria	0.000809	0.00318	CcSEcCtD
Danazol—Leukopenia—Pentoxifylline—malaria	0.000808	0.00318	CcSEcCtD
Danazol—Shock—Quinidine—malaria	0.000804	0.00316	CcSEcCtD
Danazol—Shock—Quinine—malaria	0.000804	0.00316	CcSEcCtD
Danazol—CCL2—Spinal Cord Injury—TLR4—malaria	0.000803	0.00611	CbGpPWpGaD
Danazol—Thrombocytopenia—Quinidine—malaria	0.000801	0.00315	CcSEcCtD
Danazol—Thrombocytopenia—Quinine—malaria	0.000801	0.00315	CcSEcCtD
Danazol—Palpitations—Quinidine barbiturate—malaria	0.000799	0.00314	CcSEcCtD
Danazol—GNRHR—GPCR ligand binding—ACKR1—malaria	0.000799	0.00607	CbGpPWpGaD
Danazol—Tachycardia—Quinidine—malaria	0.000798	0.00314	CcSEcCtD
Danazol—Tachycardia—Quinine—malaria	0.000798	0.00314	CcSEcCtD
Danazol—Palpitations—Pentoxifylline—malaria	0.000798	0.00314	CcSEcCtD
Danazol—Loss of consciousness—Quinidine barbiturate—malaria	0.000795	0.00312	CcSEcCtD
Danazol—Pruritus—Sulfadiazine—malaria	0.000792	0.00311	CcSEcCtD
Danazol—CCL2—AP-1 transcription factor network—IL2—malaria	0.00079	0.00601	CbGpPWpGaD
Danazol—Hyperhidrosis—Quinidine—malaria	0.00079	0.00311	CcSEcCtD
Danazol—Hyperhidrosis—Quinine—malaria	0.00079	0.00311	CcSEcCtD
Danazol—Convulsion—Quinidine barbiturate—malaria	0.000783	0.00308	CcSEcCtD
Danazol—Convulsion—Pentoxifylline—malaria	0.000782	0.00307	CcSEcCtD
Danazol—Hypertension—Pentoxifylline—malaria	0.000779	0.00306	CcSEcCtD
Danazol—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—malaria	0.000774	0.00588	CbGpPWpGaD
Danazol—CCL2—IL23-mediated signaling events—IL6—malaria	0.000774	0.00588	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—ICAM1—malaria	0.00077	0.00586	CbGpPWpGaD
Danazol—Arthralgia—Quinidine barbiturate—malaria	0.00077	0.00303	CcSEcCtD
Danazol—Anxiety—Quinidine barbiturate—malaria	0.000767	0.00302	CcSEcCtD
Danazol—Anxiety—Pentoxifylline—malaria	0.000766	0.00301	CcSEcCtD
Danazol—CCL2—Spinal Cord Injury—NOS2—malaria	0.000764	0.00581	CbGpPWpGaD
Danazol—CYP3A4—liver—malaria	0.000757	0.00624	CbGeAlD
Danazol—Musculoskeletal discomfort—Quinidine—malaria	0.000745	0.00293	CcSEcCtD
Danazol—Musculoskeletal discomfort—Quinine—malaria	0.000745	0.00293	CcSEcCtD
Danazol—CCL2—Vitamin B12 Metabolism—TNF—malaria	0.000742	0.00564	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—IFNG—malaria	0.000741	0.00563	CbGpPWpGaD
Danazol—Oedema—Quinidine barbiturate—malaria	0.000738	0.0029	CcSEcCtD
Danazol—AR—Notch-mediated HES/HEY network—KDR—malaria	0.000737	0.0056	CbGpPWpGaD
Danazol—Oedema—Pentoxifylline—malaria	0.000737	0.0029	CcSEcCtD
Danazol—Dyspepsia—Clindamycin—malaria	0.000734	0.00288	CcSEcCtD
Danazol—Shock—Quinidine barbiturate—malaria	0.000726	0.00285	CcSEcCtD
Danazol—Shock—Pentoxifylline—malaria	0.000725	0.00285	CcSEcCtD
Danazol—Thrombocytopenia—Quinidine barbiturate—malaria	0.000722	0.00284	CcSEcCtD
Danazol—Thrombocytopenia—Pentoxifylline—malaria	0.000721	0.00284	CcSEcCtD
Danazol—Tachycardia—Quinidine barbiturate—malaria	0.00072	0.00283	CcSEcCtD
Danazol—Tachycardia—Pentoxifylline—malaria	0.000719	0.00283	CcSEcCtD
Danazol—Fatigue—Clindamycin—malaria	0.000719	0.00283	CcSEcCtD
Danazol—Hyperhidrosis—Quinidine barbiturate—malaria	0.000713	0.0028	CcSEcCtD
Danazol—Constipation—Clindamycin—malaria	0.000713	0.0028	CcSEcCtD
Danazol—Hyperhidrosis—Pentoxifylline—malaria	0.000712	0.0028	CcSEcCtD
Danazol—Vomiting—Sulfadiazine—malaria	0.000712	0.0028	CcSEcCtD
Danazol—Rash—Sulfadiazine—malaria	0.000706	0.00277	CcSEcCtD
Danazol—Dermatitis—Sulfadiazine—malaria	0.000705	0.00277	CcSEcCtD
Danazol—Headache—Sulfadiazine—malaria	0.000701	0.00276	CcSEcCtD
Danazol—CCL2—TWEAK Signaling Pathway—IL6—malaria	0.000699	0.00532	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—malaria	0.000684	0.0052	CbGpPWpGaD
Danazol—Body temperature increased—Dapsone—malaria	0.000681	0.00268	CcSEcCtD
Danazol—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000672	0.00264	CcSEcCtD
Danazol—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000671	0.00264	CcSEcCtD
Danazol—ESR1—Aryl Hydrocarbon Receptor—CD36—malaria	0.000668	0.00508	CbGpPWpGaD
Danazol—Nausea—Sulfadiazine—malaria	0.000665	0.00261	CcSEcCtD
Danazol—Urticaria—Clindamycin—malaria	0.000662	0.0026	CcSEcCtD
Danazol—CCL2—Selenium Micronutrient Network—IL1B—malaria	0.000661	0.00503	CbGpPWpGaD
Danazol—Body temperature increased—Clindamycin—malaria	0.000659	0.00259	CcSEcCtD
Danazol—Urticaria—Quinine—malaria	0.00065	0.00255	CcSEcCtD
Danazol—Urticaria—Quinidine—malaria	0.00065	0.00255	CcSEcCtD
Danazol—Dyspepsia—Pentoxifylline—malaria	0.000648	0.00255	CcSEcCtD
Danazol—Body temperature increased—Quinine—malaria	0.000646	0.00254	CcSEcCtD
Danazol—Body temperature increased—Quinidine—malaria	0.000646	0.00254	CcSEcCtD
Danazol—Constipation—Quinidine barbiturate—malaria	0.000631	0.00248	CcSEcCtD
Danazol—Constipation—Pentoxifylline—malaria	0.00063	0.00248	CcSEcCtD
Danazol—CCL2—Folate Metabolism—TNF—malaria	0.000604	0.00459	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—IL6—malaria	0.000599	0.00455	CbGpPWpGaD
Danazol—Asthenia—Clindamycin—malaria	0.000598	0.00235	CcSEcCtD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—IL10—malaria	0.000592	0.0045	CbGpPWpGaD
Danazol—Pruritus—Clindamycin—malaria	0.00059	0.00232	CcSEcCtD
Danazol—Asthenia—Quinine—malaria	0.000587	0.00231	CcSEcCtD
Danazol—Asthenia—Quinidine—malaria	0.000587	0.00231	CcSEcCtD
Danazol—Urticaria—Quinidine barbiturate—malaria	0.000586	0.0023	CcSEcCtD
Danazol—CCL2—Spinal Cord Injury—IFNG—malaria	0.000586	0.00446	CbGpPWpGaD
Danazol—Urticaria—Pentoxifylline—malaria	0.000585	0.0023	CcSEcCtD
Danazol—Body temperature increased—Quinidine barbiturate—malaria	0.000583	0.00229	CcSEcCtD
Danazol—Body temperature increased—Pentoxifylline—malaria	0.000582	0.00229	CcSEcCtD
Danazol—Pruritus—Quinidine—malaria	0.000578	0.00227	CcSEcCtD
Danazol—Pruritus—Quinine—malaria	0.000578	0.00227	CcSEcCtD
Danazol—Dizziness—Clindamycin—malaria	0.000551	0.00217	CcSEcCtD
Danazol—Vomiting—Dapsone—malaria	0.000548	0.00215	CcSEcCtD
Danazol—Dizziness—Quinidine—malaria	0.000541	0.00213	CcSEcCtD
Danazol—Dizziness—Quinine—malaria	0.000541	0.00213	CcSEcCtD
Danazol—Headache—Dapsone—malaria	0.00054	0.00212	CcSEcCtD
Danazol—Vomiting—Clindamycin—malaria	0.00053	0.00208	CcSEcCtD
Danazol—Asthenia—Quinidine barbiturate—malaria	0.000529	0.00208	CcSEcCtD
Danazol—Asthenia—Pentoxifylline—malaria	0.000528	0.00208	CcSEcCtD
Danazol—Rash—Clindamycin—malaria	0.000525	0.00207	CcSEcCtD
Danazol—Dermatitis—Clindamycin—malaria	0.000525	0.00206	CcSEcCtD
Danazol—CCL2—Spinal Cord Injury—IL1B—malaria	0.000523	0.00397	CbGpPWpGaD
Danazol—Headache—Clindamycin—malaria	0.000522	0.00205	CcSEcCtD
Danazol—Pruritus—Quinidine barbiturate—malaria	0.000522	0.00205	CcSEcCtD
Danazol—Pruritus—Pentoxifylline—malaria	0.000521	0.00205	CcSEcCtD
Danazol—CCL2—Spinal Cord Injury—IL2—malaria	0.000521	0.00396	CbGpPWpGaD
Danazol—Vomiting—Quinine—malaria	0.00052	0.00204	CcSEcCtD
Danazol—Vomiting—Quinidine—malaria	0.00052	0.00204	CcSEcCtD
Danazol—AR—Notch-mediated HES/HEY network—CD4—malaria	0.000519	0.00395	CbGpPWpGaD
Danazol—Rash—Quinidine—malaria	0.000516	0.00203	CcSEcCtD
Danazol—Rash—Quinine—malaria	0.000516	0.00203	CcSEcCtD
Danazol—Dermatitis—Quinine—malaria	0.000515	0.00203	CcSEcCtD
Danazol—Dermatitis—Quinidine—malaria	0.000515	0.00203	CcSEcCtD
Danazol—Headache—Quinine—malaria	0.000512	0.00201	CcSEcCtD
Danazol—Headache—Quinidine—malaria	0.000512	0.00201	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—IL10—malaria	0.000512	0.00389	CbGpPWpGaD
Danazol—Nausea—Dapsone—malaria	0.000512	0.00201	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—IL4—malaria	0.000498	0.00379	CbGpPWpGaD
Danazol—Nausea—Clindamycin—malaria	0.000495	0.00195	CcSEcCtD
Danazol—Dizziness—Quinidine barbiturate—malaria	0.000488	0.00192	CcSEcCtD
Danazol—Dizziness—Pentoxifylline—malaria	0.000487	0.00192	CcSEcCtD
Danazol—CCL2—Folate Metabolism—IL6—malaria	0.000487	0.0037	CbGpPWpGaD
Danazol—Nausea—Quinidine—malaria	0.000486	0.00191	CcSEcCtD
Danazol—Nausea—Quinine—malaria	0.000486	0.00191	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000482	0.00367	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—TNF—malaria	0.000479	0.00365	CbGpPWpGaD
Danazol—Vomiting—Quinidine barbiturate—malaria	0.000469	0.00184	CcSEcCtD
Danazol—Vomiting—Pentoxifylline—malaria	0.000468	0.00184	CcSEcCtD
Danazol—Rash—Quinidine barbiturate—malaria	0.000465	0.00183	CcSEcCtD
Danazol—Dermatitis—Quinidine barbiturate—malaria	0.000465	0.00183	CcSEcCtD
Danazol—CCL2—AP-1 transcription factor network—IL6—malaria	0.000465	0.00353	CbGpPWpGaD
Danazol—Rash—Pentoxifylline—malaria	0.000464	0.00183	CcSEcCtD
Danazol—Dermatitis—Pentoxifylline—malaria	0.000464	0.00182	CcSEcCtD
Danazol—CCL2—TNF alpha Signaling Pathway—TNF—malaria	0.000463	0.00352	CbGpPWpGaD
Danazol—Headache—Quinidine barbiturate—malaria	0.000462	0.00182	CcSEcCtD
Danazol—Headache—Pentoxifylline—malaria	0.000461	0.00181	CcSEcCtD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—malaria	0.000456	0.00347	CbGpPWpGaD
Danazol—CYP19A1—Biological oxidations—HPGDS—malaria	0.000451	0.00343	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—NOS2—malaria	0.00045	0.00342	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—ACKR1—malaria	0.000448	0.00341	CbGpPWpGaD
Danazol—Nausea—Quinidine barbiturate—malaria	0.000438	0.00172	CcSEcCtD
Danazol—Nausea—Pentoxifylline—malaria	0.000437	0.00172	CcSEcCtD
Danazol—GNRHR—Signaling by GPCR—ACKR1—malaria	0.00041	0.00312	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—IL6—malaria	0.000387	0.00294	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TNF—malaria	0.000379	0.00288	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—IL6—malaria	0.000373	0.00284	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000371	0.00282	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL10—malaria	0.00035	0.00266	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—IFNG—malaria	0.000345	0.00263	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000316	0.0024	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—IFNG—malaria	0.000308	0.00234	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—IL6—malaria	0.000306	0.00233	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IFNG—malaria	0.000301	0.00229	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—IL2—malaria	0.000274	0.00208	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—TNF—malaria	0.000273	0.00207	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL2—malaria	0.000268	0.00204	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000267	0.00203	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ACKR1—malaria	0.000265	0.00201	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—IL1B—malaria	0.000254	0.00193	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ACKR1—malaria	0.000242	0.00184	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TLR9—malaria	0.000213	0.00162	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000206	0.00156	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TLR9—malaria	0.000195	0.00148	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL1B—malaria	0.000184	0.0014	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—IL6—malaria	0.00018	0.00137	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—DHODH—malaria	0.000176	0.00134	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000173	0.00132	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	0.000173	0.00132	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000159	0.00121	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL6—malaria	0.000157	0.0012	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ACKR1—malaria	0.000153	0.00116	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SLC4A1—malaria	0.00015	0.00114	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—IL6—malaria	0.000144	0.0011	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—DECR1—malaria	0.000141	0.00107	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—TNF—malaria	0.000133	0.00101	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—HPGDS—malaria	0.000132	0.001	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—HBB—malaria	0.000127	0.000968	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TLR9—malaria	0.000123	0.000936	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PKLR—malaria	0.000113	0.000863	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TNF—malaria	0.000113	0.000862	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL6—malaria	0.000108	0.000818	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—G6PD—malaria	0.000101	0.000769	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CD36—malaria	9.98e-05	0.000759	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—IL2—malaria	9.39e-05	0.000714	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL2—malaria	9.32e-05	0.000709	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ACKR1—malaria	8.96e-05	0.000681	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—malaria	8.73e-05	0.000664	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL2—malaria	8.53e-05	0.000648	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KDR—malaria	8.49e-05	0.000646	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—IL6—malaria	8.46e-05	0.000643	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KDR—malaria	7.77e-05	0.000591	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—HPGDS—malaria	7.71e-05	0.000587	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TLR9—malaria	7.22e-05	0.000549	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—DHFR—malaria	7.16e-05	0.000544	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SCARB1—malaria	7.08e-05	0.000539	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL2—malaria	5.51e-05	0.000419	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6—malaria	5.48e-05	0.000417	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DHODH—malaria	5.14e-05	0.000391	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL2—malaria	5.04e-05	0.000383	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—malaria	5.01e-05	0.000381	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KDR—malaria	4.9e-05	0.000373	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CD36—malaria	4.44e-05	0.000338	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC4A1—malaria	4.37e-05	0.000332	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DECR1—malaria	4.11e-05	0.000312	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HBB—malaria	3.72e-05	0.000283	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PKLR—malaria	3.31e-05	0.000252	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—malaria	3.24e-05	0.000246	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL2—malaria	3.18e-05	0.000242	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—malaria	2.96e-05	0.000225	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—G6PD—malaria	2.95e-05	0.000224	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KDR—malaria	2.88e-05	0.000219	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HPGDS—malaria	2.25e-05	0.000171	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DHFR—malaria	2.09e-05	0.000159	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SCARB1—malaria	2.07e-05	0.000157	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—malaria	1.87e-05	0.000142	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL2—malaria	1.86e-05	0.000142	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CD36—malaria	1.3e-05	9.86e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—malaria	1.1e-05	8.33e-05	CbGpPWpGaD
